Overview

21 Day Irritancy Test of Azelaic Acid Pre-foam Formulation

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the irritancy potential of azelaic acid pre-foam formulation.
Phase:
Phase 1
Details
Lead Sponsor:
Bayer
LEO Pharma
Collaborator:
Bayer
Treatments:
Azelaic acid